 | • レポートコード：B-GIR08C1006 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、がん免疫療法の世界市場について調べ、まとめました。種類別セグメントは、モノクローナル抗体、免疫チェックポイント阻害剤、免疫システム調節剤、癌ワクチン等、用途別セグメントは、等に区分しました。がん免疫療法の世界市場概観、企業動向、企業別がん免疫療法シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・がん免疫療法の市場概観 ・がん免疫療法の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・がん免疫療法の企業別販売動向、市場シェア、市場集中度、競争動向 ・がん免疫療法の世界市場規模 ・がん免疫療法の北米市場分析（アメリカ、カナダ、メキシコ等） ・がん免疫療法のアメリカ市場規模推移 ・がん免疫療法のカナダ市場規模推移 ・がん免疫療法のメキシコ市場規模推移 ・がん免疫療法のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・がん免疫療法のドイツ市場規模推移 ・がん免疫療法のイギリス市場規模推移 ・がん免疫療法のロシア市場規模推移 ・がん免疫療法のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・がん免疫療法の日本市場規模推移 ・がん免疫療法の中国市場規模推移 ・がん免疫療法の韓国市場規模推移 ・がん免疫療法のインド市場規模推移 ・がん免疫療法の東南アジア市場規模推移 ・がん免疫療法の南米市場分析（ブラジル、アルゼンチン等） ・がん免疫療法の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・がん免疫療法の種類別分析/販売量、売上、市場シェア（モノクローナル抗体、免疫チェックポイント阻害剤、免疫システム調節剤、癌ワクチン） ・がん免疫療法の用途別分析/市場規模（） ・がん免疫療法の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・がん免疫療法の販売チャネル・代理店・貿易業者・ディーラー分析 |
Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body’s natural defenses to fight cancer.
Scope of the Report:
The global Cancer Immunotherapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Immunotherapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cancer Immunotherapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Immunotherapy market by product type and applications/end industries.
Market Segment by Companies, this report covers
Amgen
AstraZeneca
Roche
Bayer
Bristol-Myers Squibb
Eli Lilly
Merck
Novartis
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Market Segment by Applications, can be divided into
Lung Cancer
Breast Cancer
Colorectal Cancer
Melanoma
Prostate Cancer
Others
Table of Contents
1 Cancer Immunotherapy Market Overview
1.1 Product Overview and Scope of Cancer Immunotherapy
1.2 Classification of Cancer Immunotherapy by Types
1.2.1 Global Cancer Immunotherapy Revenue Comparison by Types (2019-2024)
1.2.2 Global Cancer Immunotherapy Revenue Market Share by Types in 2018
1.2.3 Monoclonal Antibodies
1.2.4 Immune Checkpoint Inhibitors
1.2.5 Immune System Modulators
1.2.6 Cancer Vaccines
1.3 Global Cancer Immunotherapy Market by Application
1.3.1 Global Cancer Immunotherapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Colorectal Cancer
1.3.5 Melanoma
1.3.6 Prostate Cancer
1.3.7 Others
1.4 Global Cancer Immunotherapy Market by Regions
1.4.1 Global Cancer Immunotherapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cancer Immunotherapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Immunotherapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Immunotherapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cancer Immunotherapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Immunotherapy Status and Prospect (2014-2024)
1.5 Global Market Size of Cancer Immunotherapy (2014-2024)
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Cancer Immunotherapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 AstraZeneca
2.2.1 Business Overview
2.2.2 Cancer Immunotherapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AstraZeneca Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 Roche
2.3.1 Business Overview
2.3.2 Cancer Immunotherapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bayer
2.4.1 Business Overview
2.4.2 Cancer Immunotherapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bayer Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bristol-Myers Squibb
2.5.1 Business Overview
2.5.2 Cancer Immunotherapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol-Myers Squibb Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.6 Eli Lilly
2.6.1 Business Overview
2.6.2 Cancer Immunotherapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.7 Merck
2.7.1 Business Overview
2.7.2 Cancer Immunotherapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Cancer Immunotherapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Cancer Immunotherapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cancer Immunotherapy Market Competition, by Players
3.1 Global Cancer Immunotherapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Immunotherapy Players Market Share
3.2.2 Top 10 Cancer Immunotherapy Players Market Share
3.3 Market Competition Trend
4 Global Cancer Immunotherapy Market Size by Regions
4.1 Global Cancer Immunotherapy Revenue and Market Share by Regions
4.2 North America Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
4.3 Europe Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
4.5 South America Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
5 North America Cancer Immunotherapy Revenue by Countries
5.1 North America Cancer Immunotherapy Revenue by Countries (2014-2019)
5.2 USA Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
5.3 Canada Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
6 Europe Cancer Immunotherapy Revenue by Countries
6.1 Europe Cancer Immunotherapy Revenue by Countries (2014-2019)
6.2 Germany Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
6.3 UK Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
6.4 France Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
6.5 Russia Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
6.6 Italy Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cancer Immunotherapy Revenue by Countries
7.1 Asia-Pacific Cancer Immunotherapy Revenue by Countries (2014-2019)
7.2 China Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
7.3 Japan Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
7.4 Korea Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
7.5 India Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
8 South America Cancer Immunotherapy Revenue by Countries
8.1 South America Cancer Immunotherapy Revenue by Countries (2014-2019)
8.2 Brazil Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cancer Immunotherapy by Countries
9.1 Middle East and Africa Cancer Immunotherapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
9.3 UAE Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
10 Global Cancer Immunotherapy Market Segment by Type
10.1 Global Cancer Immunotherapy Revenue and Market Share by Type (2014-2019)
10.2 Global Cancer Immunotherapy Market Forecast by Type (2019-2024)
10.3 Monoclonal Antibodies Revenue Growth Rate (2014-2024)
10.4 Immune Checkpoint Inhibitors Revenue Growth Rate (2014-2024)
10.5 Immune System Modulators Revenue Growth Rate (2014-2024)
10.6 Cancer Vaccines Revenue Growth Rate (2014-2024)
11 Global Cancer Immunotherapy Market Segment by Application
11.1 Global Cancer Immunotherapy Revenue Market Share by Application (2014-2019)
11.2 Cancer Immunotherapy Market Forecast by Application (2019-2024)
11.3 Lung Cancer Revenue Growth (2014-2019)
11.4 Breast Cancer Revenue Growth (2014-2019)
11.5 Colorectal Cancer Revenue Growth (2014-2019)
11.6 Melanoma Revenue Growth (2014-2019)
11.7 Prostate Cancer Revenue Growth (2014-2019)
11.8 Others Revenue Growth (2014-2019)
12 Global Cancer Immunotherapy Market Size Forecast (2019-2024)
12.1 Global Cancer Immunotherapy Market Size Forecast (2019-2024)
12.2 Global Cancer Immunotherapy Market Forecast by Regions (2019-2024)
12.3 North America Cancer Immunotherapy Revenue Market Forecast (2019-2024)
12.4 Europe Cancer Immunotherapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cancer Immunotherapy Revenue Market Forecast (2019-2024)
12.6 South America Cancer Immunotherapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cancer Immunotherapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Cancer Immunotherapy Picture
Table Product Specifications of Cancer Immunotherapy
Table Global Cancer Immunotherapy and Revenue (Million USD) Market Split by Product Type
Figure Global Cancer Immunotherapy Revenue Market Share by Types in 2018
Figure Monoclonal Antibodies Picture
Figure Immune Checkpoint Inhibitors Picture
Figure Immune System Modulators Picture
Figure Cancer Vaccines Picture
Table Global Cancer Immunotherapy Revenue (Million USD) by Application (2014-2024)
Figure Cancer Immunotherapy Revenue Market Share by Applications in 2018
Figure Lung Cancer Picture
Figure Breast Cancer Picture
Figure Colorectal Cancer Picture
Figure Melanoma Picture
Figure Prostate Cancer Picture
Figure Others Picture
Table Global Market Cancer Immunotherapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Cancer Immunotherapy Type and Applications
Table Amgen Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Cancer Immunotherapy Type and Applications
Table AstraZeneca Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Cancer Immunotherapy Type and Applications
Table Roche Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Cancer Immunotherapy Type and Applications
Table Bayer Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Cancer Immunotherapy Type and Applications
Table Bristol-Myers Squibb Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Cancer Immunotherapy Type and Applications
Table Eli Lilly Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Cancer Immunotherapy Type and Applications
Table Merck Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Cancer Immunotherapy Type and Applications
Table Novartis Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Cancer Immunotherapy Type and Applications
Table Pfizer Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global Cancer Immunotherapy Revenue (Million USD) by Players (2014-2019)
Table Global Cancer Immunotherapy Revenue Share by Players (2014-2019)
Figure Global Cancer Immunotherapy Revenue Share by Players in 2017
Figure Global Cancer Immunotherapy Revenue Share by Players in 2018
Figure Global Top 5 Players Cancer Immunotherapy Revenue Market Share in 2018
Figure Global Top 10 Players Cancer Immunotherapy Revenue Market Share in 2018
Figure Global Cancer Immunotherapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Cancer Immunotherapy Revenue (Million USD) by Regions (2014-2019)
Table Global Cancer Immunotherapy Revenue Market Share by Regions (2014-2019)
Figure Global Cancer Immunotherapy Revenue Market Share by Regions (2014-2019)
Figure Global Cancer Immunotherapy Revenue Market Share by Regions in 2018
Figure North America Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Europe Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure South America Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Table North America Cancer Immunotherapy Revenue by Countries (2014-2019)
Table North America Cancer Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure North America Cancer Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure North America Cancer Immunotherapy Revenue Market Share by Countries in 2018
Figure USA Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Canada Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Mexico Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Table Europe Cancer Immunotherapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Cancer Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Europe Cancer Immunotherapy Revenue Market Share by Countries in 2018
Figure Germany Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure UK Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure France Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Russia Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Italy Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Cancer Immunotherapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Cancer Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Cancer Immunotherapy Revenue Market Share by Countries in 2018
Figure China Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Japan Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Korea Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure India Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Table South America Cancer Immunotherapy Revenue by Countries (2014-2019)
Table South America Cancer Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure South America Cancer Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure South America Cancer Immunotherapy Revenue Market Share by Countries in 2018
Figure Brazil Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Argentina Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Colombia Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Cancer Immunotherapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Cancer Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cancer Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cancer Immunotherapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure UAE Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Egypt Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Figure South Africa Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
Table Global Cancer Immunotherapy Revenue (Million USD) by Type (2014-2019)
Table Global Cancer Immunotherapy Revenue Share by Type (2014-2019)
Figure Global Cancer Immunotherapy Revenue Share by Type (2014-2019)
Figure Global Cancer Immunotherapy Revenue Share by Type in 2018
Table Global Cancer Immunotherapy Revenue Forecast by Type (2019-2024)
Figure Global Cancer Immunotherapy Market Share Forecast by Type (2019-2024)
Figure Global Monoclonal Antibodies Revenue Growth Rate (2014-2019)
Figure Global Immune Checkpoint Inhibitors Revenue Growth Rate (2014-2019)
Figure Global Immune System Modulators Revenue Growth Rate (2014-2019)
Figure Global Cancer Vaccines Revenue Growth Rate (2014-2019)
Table Global Cancer Immunotherapy Revenue by Application (2014-2019)
Table Global Cancer Immunotherapy Revenue Share by Application (2014-2019)
Figure Global Cancer Immunotherapy Revenue Share by Application (2014-2019)
Figure Global Cancer Immunotherapy Revenue Share by Application in 2018
Table Global Cancer Immunotherapy Revenue Forecast by Application (2019-2024)
Figure Global Cancer Immunotherapy Market Share Forecast by Application (2019-2024)
Figure Global Lung Cancer Revenue Growth Rate (2014-2019)
Figure Global Breast Cancer Revenue Growth Rate (2014-2019)
Figure Global Colorectal Cancer Revenue Growth Rate (2014-2019)
Figure Global Melanoma Revenue Growth Rate (2014-2019)
Figure Global Prostate Cancer Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Cancer Immunotherapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Cancer Immunotherapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Cancer Immunotherapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Cancer Immunotherapy Revenue Market Forecast (2019-2024)
Figure Europe Cancer Immunotherapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Cancer Immunotherapy Revenue Market Forecast (2019-2024)
Figure South America Cancer Immunotherapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Cancer Immunotherapy Revenue Market Forecast (2019-2024)
癌免疫療法創薬アウトソーシングの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Cancer Immunotherapy Drug Discovery Outsourcing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years…- 養子細胞免疫療法の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Adoptive cellular immunity is the transfer of lymphocytes from the donor to the recipient to enhance its cellular immunity. Scope of the Report: The global Adoptive Cellular Immunotherapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing a…
- 乳がんPARP阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global PARP Inhibitors for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially i…
- 世界の腎臓がん市場：市場規模・現状・予測 Kidney cancer is a type of cancer that starts in the cells in the kidney.The growth of the market is attributed to increasing incidence of kidney cancers and increasing ill lifestyle changes which gets worsen with addiction of tobacco and alcohol. Furthermore, overexposure to radiation during treatm…
- がん生物製剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Cancer Biologic is a medicinal preparation created by a biological process, it is used to treatment and remission cancer symptoms. Scope of the Report: The global Cancer Biologics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR…